Glenmark Pharmaceuticals Limited — Important, 09-05-2025: General Updates
09-05-2025 | 10:34 pm
09-05-2025 | 10:34 pm
Glenmark Pharmaceuticals has announced a board meeting to review the financial results for the quarter and half-year. Its Indore manufacturing facility received an "Official Action Indicated" classification from the US FDA after inspection. Glenmark will engage with the FDA to resolve compliance issues, which could delay production and exports from the Indore plant until approval is restored.
No comments yet. Be the first to comment!
